Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide

European Journal of Neuroscience

Volumn 28, Issue 4, 2008, Pages 633-641

  Loría, Frida ^a   Petrosino, Stefania ^b   Mestre, Leyre ^a   Spagnolo, Alessandra ^a   Correa, Fernando ^a   Hernangómez, Miriam ^a   Guaza, Carmen ^a   Di Marzo, Vincenzo ^b   Docagne, Fabian ^a,c  

^a INSTITUTO CAJAL   (Spain)

^b CNR   (Italy)

^c GIP CYCERON   (France)

Author keywords

Cannabinoids; Mus musculus; Neuroinflammation; TaqMan RT PCR; Theiler's virus

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ACYLGLYCEROL LIPASE; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CYTOKINE; ENDOCANNABINOID; FATTY ACID AMIDASE; LIPOPROTEIN LIPASE; PALMIDROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHOSPHOLIPASE D;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DEGRADATION; FEMALE; MOTOR DYSFUNCTION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; THERAPY EFFECT; VIRUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIVIRAL AGENTS; CYTOKINES; DISEASE MODELS, ANIMAL; ENDOCANNABINOIDS; FEMALE; HUMANS; MICE; MOTOR ACTIVITY; MULTIPLE SCLEROSIS; PAIN; PALMITIC ACIDS; PPAR ALPHA; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; ROTAROD PERFORMANCE TEST; SIGNAL TRANSDUCTION; THEILOVIRUS;

EID: 49249094482     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2008.06377.x     Document Type: Article

References (40)

1. Amantea, D., Spagnuolo, P., Bari, M., Fezza, F., Mazzei, C., Tassorelli, C., Morrone, L.A., Corasaniti, M.T., Maccarrone, M. Bagetta, G. (2007) Modulation of the endocannabinoid system by focal brain ischemia in the rat is involved in neuroprotection afforded by 17beta-estradiol. FEBS J., 274, 4464 4775.
2. Baker, D., Pryce, G., Croxford, J.L., Brown, P., Pertwee, R.G., Huffman, J.W. Layward, L. (2000) Cannabinoids control spasticity and tremor in a multiple sclerosis model. Nature, 404, 84 87.
3. Baker, D., Pryce, G., Croxford, J.L., Brown, P., Pertwee, R.G., Makriyannis, A., Khanolkar, A., Layward, L., Fezza, F., Bisogno, T. Di Marzo, V. (2001) Endocannabinoids control spasticity in a multiple sclerosis model. FASEB J., 15, 300 302.
4. 2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis. J. Neurosci., 27, 2396 2402.
5. Bisogno, T. Di Marzo, V. (2007) Short- and long-term plasticity of the endocannabinoid system in neuropsychiatric and neurological disorders. Pharmacol. Res., 56, 428 442.
6. Bisogno, T., Martire, A., Petrosino, S., Popoli, P. Di Marzo, V. (2007) Symptom-related changes of endocannabinoid and palmitoylethanolamide levels in brain areas of R6/;2 mice, a transgenic model of Huntington's disease. Neurochem. Int., 52, 307 313.
7. Brown, A.J. (2007) Novel cannabinoid receptors. Br. J. Pharmacol., 152, 567 575.
8. Cabranes, A., Venderova, K., de Lago, E., Fezza, F., Sánchez, A., Mestre, L., Valenti, M., García-Merino, A., Ramos, J.A., Di Marzo, V. Fernández-Ruiz, J. (2005) Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/;or vanilloid receptors in a rat model of multiple sclerosis. Neurobiol. Dis., 20, 207 217.
9. Centonze, D., Rossi, S., Finazzi-Agro, A., Bernardi, G. Maccarrone, M. (2007) The (endo)cannabinoid system in multiple sclerosis and amyotrophic lateral sclerosis. Int. Rev. Neurobiol., 82, 171 186.
10. Chon, S.H., Zhou, Y.X., Dixon, J.L. Storch, J. (2007) Intestinal monoacylglycerol metabolism: developmental and nutritional regulation of monoacylglycerol lipase and monoacylglycerol acyltransferase. J. Biol. Chem., 282, 33346 33357.
11. Cunard, R., DiCampli, D., Archer, D.C., Stevenson, J.L., Ricote, M., Glass, C.K. Kelly, C.J. (2002) WY14,643, a PPAR alpha ligand, has profound effects on immune responses in vivo. J. Immunol., 169, 6806 6812.
12. De Filippis, D., D'Amico, A., Cinelli, M.P., Esposito, G., Di Marzo, V. Iuvone, T. (2008) Adelmidrol, a palmitoylethanolamide analog, reduces chronic inflammation in a carrageenin-granuloma model in rats. J. Cell Mol. Med., In press.
13. De Petrocellis, L., Marini, P., Matias, I., Moriello, A.S., Starowicz, K., Cristino, L., Nigam, S. Di Marzo, V. (2007) Mechanisms for the coupling of cannabinoid receptors to intracellular calcium mobilization in rat insulinoma beta-cells. Exp. Cell Res., 313, 2993 3004.
14. Di Marzo, V., Goparaju, S.K., Wang, L., Liu, J., Batkai, S., Jarai, Z., Fezza, F., Miura, G.I., Palmiter, R.D., Sugiura, T. Kunos, G. (2001a) Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature, 410, 822 825.
15. Di Marzo, V., Melck, D., Orlando, P., Bisogno, T., Zagoory, O., Bifulco, M., Vogel, Z. De Petrocellis, L. (2001b) Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells. Biochem. J., 358, 249 255.
16. 2 receptor activation. Mol. Cell. Neurosci., 34, 551 561.
17. Franklin, A., Parmentier-Batteur, S., Walter, L., Greenberg, D.A. Stella, N. (2003) Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility. J. Neurosci., 23, 7767 7775.
18. Genovese, T., Esposito, E., Mazzon, E., Di Paola, R., Meli, R., Bramanti, P., Piomeli, D., Calignano, A. Cuzzocrea, S. (2008) Effects of palmitoylethanolamide on signaling pathways implicated in the development of spinal cord injury. J. Pharmacol. Exp. Ther., 326, 12 23.
19. 2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice. Eur. J. Pharmacol., 546, 60 68.
20. Heneka, M.T., Landreth, G.E. Hull, M. (2007) Drug insight: effects mediated by peroxisome proliferator-activated receptor-gamma in CNS disorders. Nat. Clin. Pract. Neurol., 3, 496 504.
21. Lambert, D.M. Di Marzo, V. (1999) The palmitoylethanolamide and oleamide enigmas : are these two fatty acid amides cannabimimetic? Curr. Med. Chem., 6, 757 773.
22. Lledo, A., Borrell, J. Guaza, C. (1999) Dexamethasone regulation of interleukin-1-receptors in the hippocampus of Theiler's virus-infected mice: effects on virus-mediated demyelination. Eur. J. Pharmacol., 372, 75 83.
23. LoVerme, J., La Rana, G., Russo, R., Calignano, A. Piomelli, D. (2005) The search for the palmitoylethanolamide receptor. Life Sci., 77, 1685 1698.
24. 2 receptor in microglial cells in response to inflammatory stimuli. J. Neurochem., 95, 437 445.
25. Mestre, L., Correa, F., Arevalo-Martin, A., Molina-Holgado, E., Valenti, M., Ortar, G., Di Marzo, V. Guaza, C. (2005) Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis. J. Neurochem., 92, 1327 1339.
26. Muccioli, G.G. Stella, N. (2007) Microglia produce and hydrolyze palmitoylethanolamide. Neuropharmacology, 54, 16 22.
27. O'Sullivan, S.E. (2007) Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors. Br. J. Pharmacol., 152, 576 582.
28. Ortega-Gutierrez, S., Molina-Holgado, E., Arevalo-Martin, A., Correa, F., Viso, A., Lopez-Rodriguez, M.L., Di Marzo, V. Guaza, C. (2005) Activation of the endocannabinoid system as therapeutic approach in a murine model of multiple sclerosis. FASEB J., 19, 1338 1340.
29. Pachner, A.R., Brady, J. Narayan, K. (2007) Antibody-secreting cells in the central nervous system in an animal model of MS: phenotype, association with disability, and in vitro production of antibody. J. Neuroimmunol., 190, 112 120.
30. Palazuelos, J., Davoust, N., Julien, B., Hatterer, E., Aguado, T., Mechoulam, R., Benito, C., Romero, J., Silva, A., Guzman, M., Nataf, S. Galve-Roperh, I. (2008) The CB2 cannabinoid receptor controls myeloid progenitor trafficking. J. Biol. Chem., 283, 13320 13329.
31. Petrosino, S., Palazzo, E., de Novellis, V., Bisogno, T., Rossi, F., Maione, S. Di Marzo, V. (2007) Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats. Neuropharmacology, 52, 415 422.
32. Sheerin, A.H., Zhang, X., Saucier, D.M. Corcoran, M.E. (2004) Selective antiepileptic effects of N-palmitoylethanolamide, a putative endocannabinoid. Epilepsia, 45, 1184 1188.
33. Skaper, S.D., Buriani, A., Dal Toso, R., Petrelli, L., Romanello, S., Facci, L. Leon, A. (1996) The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons. Proc. Natl Acad. Sci. USA, 93, 3984 3989.
34. Starowicz, K., Nigam, S. Di Marzo, V. (2007) Biochemistry and pharmacology of endovanilloids. Pharmacol. Ther., 114, 13 33.
35. Tsakiri, N., Kimber, I., Rothwell, N.J. Pinteaux, E. (2008) Differential effects of interleukin-1 alpha and beta on interleukin-6 and chemokine synthesis in neurones. Mol. Cell. Neurosci., 38, 259 265.
36. Tsuboi, K., Sun, Y.X., Okamoto, Y., Araki, N., Tonai, T. Ueda, N. (2005) Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase. J. Biol. Chem., 280, 11082 11092.
37. Tsunoda, I., Kuang, L.Q., Libbey, J.E. Fujinami, R.S. (2003) Axonal injury heralds virus-induced demyelination. Am. J. Pathol., 162, 1259 1269.
38. Ure, D. Rodriguez, M. (2000) Extensive injury of descending neurons demonstrated by retrograde labeling in a virus-induced murine model of chronic inflammatory demyelination. J. Neuropathol. Exp. Neurol., 59, 664 678.
39. Witting, A., Chen, L., Cudaback, E., Straiker, A., Walter, L., Rickman, B., Moller, T., Brosnan, C. Stella, N. (2006) Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection. Proc. Natl Acad. Sci. USA, 103, 6362 6367.
40. 2 and P2X7-immunoreactivities are increased in activated microglial cells/;macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord. BMC Neurol., 6, 12.